Michael J Fox Foundation Tour de Fox Series 2016

Global update

Author: Parkinson's Life editorsPublished: 2 June 2016

Prep: Cook: Serves:

The popular series of cycling events in the United States and Canada, organised by Team Fox, once again invites cyclists of all ages and abilities to grab their helmets, pump up their tyres and raise money for Parkinson’s disease research

From scenic rides taken at a leisurely pace to physically demanding mountainous routes the Tour de Fox Series offers something for everyone, of all cycling abilities.

Registration fee is US$50 per person and riders are also required to raise a minimum of US$200 by the day of the ride. You can register here.

The 2016 event schedule is as follows:

16 July: Great Lakes (Cleveland, Ohio, US)
20 August: Pacific Northwest (Vancouver, British Columbia, Canada)
27 August: Sonoma Wine Country (Santa Rosa, California, US)

Each event will start at 12pm local time and will host a finish-line festival with live music, food trucks and kid-friendly activities. Non-cyclists are invited to join finish-line festivities and all are welcome to participate and connect with the local Parkinson’s community.

Donations to the Tour de Fox will be accepted through the end of 2016.

Image credit: Tour de Fox facebook page

Read our interview with Sam Fox here

Last Month

Next Month

Go Back

Share this story

Comments

Interviews

“There is nothing wrong with my head and I will not be judged by my condition”

The latest in our monthly series

Diana Levine: taking photos for a cure

An interview with Parkinson’s campaigner and photographer Diana Levine

Parkinson’s cookbook receives royal reception in Belgium

New innovative cookbook offers specialised Parkinson’s recipes

New study brings scientists a “vital step” closer to understanding Parkinson’s disease

A new study from scientists at the University of Cambridge, UK, has brought researchers “a vital step” closer to discovering the origins of Parkinson’s disease. The research, published in the scientific journal ‘Nature Communications’, offered insights on the protein alpha-synuclein, which clumps together in the neurons of people with Parkinson’s. The study focused on how the protein functions in those without the condition and revealed that it sticks to the inner side of the plasma membrane of nerve cells, but not the outer membrane – an insight that could help in the search for a cure. Lead study author, Dr Giuliana Fusco, said: “This study could unlock more information about this debilitating neurodegenerative disorder that can leave people unable to walk and talk. If we want to cure Parkinson’s, first we need to understand the function of alpha-synuclein, a protein present in everyone’s brains.”

Could a prostate drug lower the risk of Parkinson’s disease?

Researchers in the US, Denmark and China have found that a type of medication used to treat enlarged prostate, known as alpha-blockers, is associated with a lower risk of Parkinson’s disease. As part of the study, the research team analysed patient data from 150,000 men using medications like the alpha-blocker terazosin – which has previously been shown to slow Parkinson’s disease progression in animals – and compared their findings to data from 150,000 men using the alpha-blocker tamsulosin. They found that men taking terazosin were 12 to 37% less likely to develop Parkinson’s disease. Jacob Simmering, corresponding author of the study, said: “Despite the relative differences in population and health care system structure, we found a similar protective effect in both [the US and Denmark]. “If these results are confirmed through further investigation, especially a randomised clinical trial, terazosin may provide neuroprotection and potentially prevent – and not just manage…

People with Parkinson’s disease have a “high interest” in herbal drugs, study finds

Researchers in Germany conducted a survey to assess how people with Parkinson’s disease perceive and experience medical cannabis. As part of the study, the team analysed answers from more than 1,300 people with Parkinson’s. They found that 65% of participants who did not use medical cannabis were interested in it, but lacked knowledge and feared side effects. Around 8% of participants reported using cannabis; of these, 54% reported beneficial effects – including 40% who reported reduced pain. Professor Dr Carsten Buhmann, lead study investigator, said: “Our data confirm that Parkinson’s disease patients have a high interest in treatment with medicinal cannabis […]. The data reported here may help physicians decide which patients could benefit, which symptoms could be addressed, and which type of cannabinoid and route of administration might be suitable. “It has to be stressed, though, that our findings are based on subjective patient reports and that clinically appropriate…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Email
This field is for validation purposes and should be left unchanged.

Michael J Fox Foundation Tour de Fox Series 2016

Global update

Author: Parkinson's Life editorsPublished: 2 June 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Interviews

“There is nothing wrong with my head and I will not be judged by my condition”

Perspectives

Diana Levine: taking photos for a cure

Resources & Tools

Parkinson’s cookbook receives royal reception in Belgium

New study brings scientists a “vital step” closer to understanding Parkinson’s disease

Could a prostate drug lower the risk of Parkinson’s disease?

People with Parkinson’s disease have a “high interest” in herbal drugs, study finds

{title}

Subscribe

Michael J Fox Foundation Tour de Fox Series 2016

Global update

Author: Parkinson's Life editorsPublished: 2 June 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Interviews

“There is nothing wrong with my head and I will not be judged by my condition”

Perspectives

Diana Levine: taking photos for a cure

Resources & Tools

Parkinson’s cookbook receives royal reception in Belgium

New study brings scientists a “vital step” closer to understanding Parkinson’s disease

Could a prostate drug lower the risk of Parkinson’s disease?

People with Parkinson’s disease have a “high interest” in herbal drugs, study finds

{title}

Subscribe

Sign in